| |
| |
|
| Insider
Information: |
Velleca Mark A. |
| Relationship: |
|
| City: |
Research Triangle Park |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
162,522 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$600,216 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
162,522 |
|
|
| Total
Value |
$600,216 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
G1 Therapeutics Inc |
GTHX |
|
2023-08-08 |
116,000 |
2017-12-18 |
0 |
Premium* |
|
|
Black Diamond Therapeutics, Inc. |
BDTX |
|
2023-09-15 |
46,522 |
2022-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
88 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-02-17 |
4 |
AS |
$27.59 |
$276,433 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-02-18 |
4 |
AS |
$26.02 |
$260,152 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-04-13 |
4 |
AS |
$23.89 |
$238,865 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-04-14 |
4 |
AS |
$24.53 |
$245,272 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-04-15 |
4 |
AS |
$24.96 |
$249,631 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-05-11 |
4 |
AS |
$19.10 |
$190,997 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-05-12 |
4 |
AS |
$20.07 |
$200,691 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-05-13 |
4 |
AS |
$20.54 |
$205,413 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-06-15 |
4 |
AS |
$22.39 |
$223,909 |
D/D |
(10,000) |
61,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-06-16 |
4 |
AS |
$21.74 |
$217,384 |
D/D |
(10,000) |
61,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-06-17 |
4 |
AS |
$21.77 |
$217,728 |
D/D |
(10,000) |
61,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-07-13 |
4 |
AS |
$19.45 |
$194,536 |
D/D |
(10,000) |
61,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-07-14 |
4 |
AS |
$19.08 |
$190,824 |
D/D |
(10,000) |
61,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-07-15 |
4 |
AS |
$18.49 |
$184,898 |
D/D |
(10,000) |
61,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2022-08-16 |
4 |
AS |
$12.64 |
$1,010,904 |
D/D |
(80,000) |
116,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2022-09-20 |
4 |
AS |
$13.50 |
$270,044 |
D/D |
(20,000) |
116,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2022-10-18 |
4 |
AS |
$11.70 |
$175,490 |
D/D |
(15,000) |
116,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2023-08-08 |
4 |
AS |
$2.00 |
$119,974 |
D/D |
(60,000) |
116,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-06-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
9,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2017-12-18 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-01-16 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-02-15 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-03-15 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-04-16 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-05-15 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
88 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
